Home
/
ORTHOPEDIATRICS CORP
/
Financials
/
Quarterly
ORTHOPEDIATRICS CORP — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ORTHOPEDIATRICS CORP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2019
Jun 30, 2019
$18.20M
Aug 13, 2019
Q1
2019
Mar 31, 2019
$14.66M
May 9, 2019
Q3
2018
Sep 30, 2018
$15.82M
Oct 31, 2018
Q2
2019
Jun 30, 2018
$15.08M
Aug 13, 2019
Q1
2019
Mar 31, 2018
$12.09M
May 9, 2019
Q3
2018
Sep 30, 2017
$12.38M
Oct 31, 2018
Q2
2018
Jun 30, 2017
$11.80M
Aug 9, 2018
Q1
2018
Mar 31, 2017
$9.76M
May 15, 2018
Q3
2017
Sep 30, 2016
$10.14M
Nov 13, 2017
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$61.25M
Oct 29, 2025
Q2
2025
Jun 30, 2025
$61.08M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$52.41M
May 8, 2025
Q3
2025
Sep 30, 2024
$54.57M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$52.80M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$44.69M
May 8, 2025
Q3
2024
Sep 30, 2023
$39.97M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$39.56M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$31.59M
May 7, 2024
Q3
2023
Sep 30, 2022
$34.95M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$32.93M
Aug 1, 2023
Q1
2023
Mar 31, 2022
$23.42M
May 2, 2023
Q3
2022
Sep 30, 2021
$25.08M
Nov 1, 2022
Q2
2022
Jun 30, 2021
$26.70M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$21.46M
May 5, 2022
Q3
2021
Sep 30, 2020
$22.21M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$13.59M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$16.36M
May 6, 2021
Q3
2020
Sep 30, 2019
$20.74M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$18.20M
Aug 6, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($11.77M)
Oct 29, 2025
Q2
2025
Jun 30, 2025
($7.11M)
Aug 6, 2025
Q3
2025
Jun 30, 2025
($7.11M)
Oct 29, 2025
Q2
2025
Mar 31, 2025
($10.66M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($10.66M)
May 8, 2025
Q3
2025
Mar 31, 2025
($10.66M)
Oct 29, 2025
Q3
2025
Sep 30, 2024
($7.92M)
Oct 29, 2025
Q3
2025
Jun 30, 2024
($6.03M)
Oct 29, 2025
Q2
2025
Jun 30, 2024
($6.03M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($7.81M)
May 8, 2025
Q3
2025
Mar 31, 2024
($7.81M)
Oct 29, 2025
Q2
2025
Mar 31, 2024
($7.81M)
Aug 6, 2025
Q3
2024
Sep 30, 2023
($4.59M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($2.89M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($2.89M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($6.81M)
May 7, 2024
Q3
2024
Mar 31, 2023
($6.81M)
Nov 7, 2024
Q2
2024
Mar 31, 2023
($6.81M)
Aug 6, 2024
Q3
2023
Sep 30, 2022
$18.54M
Nov 7, 2023
Q2
2023
Jun 30, 2022
($333.0K)
Aug 1, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($9.43M)
Oct 29, 2025
Q2
2025
Jun 30, 2025
($10.66M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($10.98M)
May 8, 2025
Q3
2025
Sep 30, 2024
($5.57M)
Oct 29, 2025
Q2
2025
Jun 30, 2024
($5.67M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($9.72M)
May 8, 2025
Q3
2024
Sep 30, 2023
($4.51M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($5.59M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($8.59M)
May 7, 2024
Q3
2023
Sep 30, 2022
($6.96M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($3.74M)
Aug 1, 2023
Q1
2023
Mar 31, 2022
($6.39M)
May 2, 2023
Q3
2022
Sep 30, 2021
($3.64M)
Nov 1, 2022
Q2
2022
Jun 30, 2021
($2.85M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($5.97M)
May 5, 2022
Q3
2021
Sep 30, 2020
($2.50M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($7.02M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($4.50M)
May 6, 2021
Q3
2020
Sep 30, 2019
($1.54M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($1.79M)
Aug 6, 2020